Chairman & CEO
Dr. Ethan Shen
Founder, Chair, and CEO of YD Biopharma, JY Biomedical, and EG Biomed
Dr. Ethan Shen is a visionary entrepreneur and academic leader dedicated to transforming global healthcare through innovation and excellence. With over two decades of experience in biotechnology, translational medicine, and leadership, Dr. Shen has established a reputation as a pioneer in the field.
"At YD Biopharma, we believe in the power of science to create a healthier tomorrow. Together, we can redefine the future of healthcare and bring life-changing solutions to those who need them most"
Academic Excellence
PhD in Translational Medicine (2024)
Academia Sinica and Taipei Medical University (Top 250 in Clinical and Health studies).
EMBA (2016)
Fudan University (Global Rank: 36) and National Taiwan University (Global Rank: Top 125 in Business and Economics).
Graduate Certificate in Financial Research (2006)
City University of New York, Baruch College.
Bachelor of Pharmacy (2000)
Taipei Medical University.
Professional Achievements
Securing 10 patents and over USD$125,000 in research grants.
Publishing research in high-impact journals such as Biomolecules and Cancers.
Serving Top 10 global pharmaceutical companies, including Roche, Novartis, Sandoz, and Alcon.
Entrepreneurial Ventures
YD Biopharma
From a clinical drug supplier to a leader in precision medicine and exosome therapies.
JY Biomedical
Innovating cancer vaccines, cell therapies, and antibody development in partnership with Hexun Biosciences and 3D Global Biotech.
EG Biomed
Specializing in early cancer detection with liquid biopsies featuring industry-leading sensitivity, and backed by Taipei Medical University.
Philanthropy and Leadership
YuDing Global Cancer Research Foundation
Awarded USD$25,000 in research grants since 2022.
Taiwan Chronic Disease Healthcare Association
Founded in 2016, growing to 89 members, advancing chronic disease care.
